WHO approves emergency use of Chinese vaccine Sinovac

The World Health Organization (WHO) has approved the Chinese COVID-19 vaccine Sinovac-CoronaVac for emergency use. This was reported Tuesday, June 1, by the publication Sohu.

“WHO today approved the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries, funders, procurement agencies and communities confidence that it meets international standards for safety, efficacy and production,” WHO said in a statement.

The vaccine is produced by Beijing-based pharmaceutical company Sinovac.

Earlier, on May 7, WHO Director General Tedros Adanom Gebreyesus said the organization recommended the vaccine from the Chinese company Sinopharm for emergency use. He said the move expanded the list of COVID-19 immunization drugs that can be purchased through the international COVAX mechanism.

On Oct. 9, 2020, Chinese Foreign Ministry spokeswoman Hua Chunying announced that China had signed an agreement with GAVI (Global Alliance for Vaccines and Immunization) to formally join COVAX.

According to BBC News, the Sinovac-CoronaVac vaccine has been approved for emergency use in high-risk groups in China since July 2020. On January 13, 2021 its use was approved in Turkey. However, data on the effectiveness of the vaccine vary. Thus, the drug trials in Brazil in January showed 50.4% efficacy, while in Indonesia and Turkey – 65.3% and 91.5%, respectively.